ArticleBMC microbiology2026
Analysis of mobile genetic elements carrying mcr genes in clinical Leclercia spp. isolates.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Distribution and Genome Epidemiological Characteristics ofFoods (Basel, Switzerland) · 2026Article
- Identification ofAntibiotics (Basel, Switzerland) · 2026Article
- Persistence and Environmental Dissemination of a NovelMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLeclercia adecarboxylata is an emerging clinical pathogen within the Enterobacteriaceae family and causes infections in immunocompromised and immunocompetent patients. It frequently exhibits resistance to a broad spectrum of β-lactams as well as to colistin, which is a last-resort antibiotic against multidrug-resistant Gram-negative bacteria. The global spread of mcr genes poses a serious public health concern. This study aimed to examine the prevalence and genetic contexts of mcr genes in clinical Leclercia spp. isolates from China.
resultsThis study identified three mobile colistin resistance genes, namely, mcr-9.1, mcr-9.2, and a novel variant mcr-11.1, among 11 clinical Leclercia isolates. Some of these isolates were assigned to two novel species: Leclercia sp. LecN1 and Leclercia sp. LecN2. mcr-11.1 showed the highest sequence similarity to mcr-9.1 and was located within two novel chromosomal integrative mobile elements (IMEs): Tn6572 and Tn6573. mcr-9.1 was carried by a chromosomally located Tn7-family/Tn6230-subfamily transposon (Tn6574) and by three IncHI2 plasmids: p707804-mcr, p1106151-mcr, and pJ807-mcr. Meanwhile, mcr-9.2 was identified in plasmid pP10164-2. These mcr genes showed diverse local genetic contexts, including mcr-11.1–wbuC–qseCB in Tn6573-family IMEs as well as IS903B–mcr-9.1–wbuC–qseCB–exeA–int–IS26 and its variants within the Tn6230-related regions of Tn6574 and IncHI2 plasmids. Tn1696-related regions carried multiple mobile genetic elements (MGEs), further facilitating the dissemination of various antibiotic resistance genes (ARGs).
conclusionsIn clinical Leclercia spp. isolates, this study identified a novel colistin resistance gene (mcr-11.1), three novel chromosomal MGEs (including Tn6572–Tn6574), as well as evidence for two new putative species. Along with four identified plasmids, these chromosomal MGEs demonstrated diverse mcr genetic contexts and suggested great potentials for the dissemination of ARGs. This study highlighted a concerning mechanism for mcr gene transfer, providing an urgent indication for ongoing resistance surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.